Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
about
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
description
clinical trial
@en
klinisch onderzoek
@nl
name
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
@en
type
label
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
@en
prefLabel
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
@en
P1050
P1476
A Phase II Study to Evaluate t ...... ntolerant to JAK1/2 Inhibitors
@en
P1813
ESSENTIAL
@en
P3098
NCT03627403
P580
2019-03-14T00:00:00Z
P582
2024-03-14T00:00:00Z